chr4-86701350-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080683.3(PTPN13):āc.744T>Gā(p.Asp248Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000908 in 1,612,720 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_080683.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTPN13 | NM_080683.3 | c.744T>G | p.Asp248Glu | missense_variant | 7/48 | ENST00000411767.7 | NP_542414.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTPN13 | ENST00000411767.7 | c.744T>G | p.Asp248Glu | missense_variant | 7/48 | 1 | NM_080683.3 | ENSP00000407249.2 |
Frequencies
GnomAD3 genomes AF: 0.000861 AC: 131AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000647 AC: 160AN: 247374Hom.: 0 AF XY: 0.000701 AC XY: 94AN XY: 134164
GnomAD4 exome AF: 0.000913 AC: 1334AN: 1460400Hom.: 1 Cov.: 31 AF XY: 0.000885 AC XY: 643AN XY: 726448
GnomAD4 genome AF: 0.000860 AC: 131AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.000765 AC XY: 57AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2021 | The c.744T>G (p.D248E) alteration is located in exon 7 (coding exon 6) of the PTPN13 gene. This alteration results from a T to G substitution at nucleotide position 744, causing the aspartic acid (D) at amino acid position 248 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at